ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¿ÎÌâ×é¡°ÅÁ½ðÉ­²¡Ç±ÔÚÉúÎï±ê¼ÇÎïµÄÉúÎï³ÉÏñÓ«¹â̽Õ롱ÔÚChemical Society Reviews½ÒÏþ

¸å¼þȪԴ£º£º£ºÒ©Ñ§Ôº£¨ÉîÛÚ£© ÔĶÁÁ¿£º£º£º

ÅÁ½ðÉ­²¡(Parkinson's disease£¬£¬£¬PD), ÊÇÒ»ÖÖÖÐÊàÉñ¾­ÏµÍ³ÐÔÍËÐÐÐÔ¼²²¡£¡£¡£¡£¬£¬£¬ÓÖ³ÆÕð²üÂéľ£¬£¬£¬¶à·¢ÓÚÍíÄêȺÌå¡£¡£¡£¡£PD×÷ΪµÚ¶þ´óÉñ¾­ÍËÐÐÐÔ¼²²¡£¡£¡£¡£¬£¬£¬½ö´ÎÓÚ°¢¶û´Äº£Ä¬²¡¡£¡£¡£¡£¾Ýͳ¼Æ£¬£¬£¬ÎÒ¹úPD»¼ÕßÈËÊýÏÖÔÚ½ü300Íò£¬£¬£¬ÇÒÒÔÿÄê10ÍòµÄËÙÂÊÔÚµÝÔö¡£¡£¡£¡£Ëæ×ÅÎÒ¹úÉú³ÝÀÏÁ仯µÄ¼Ó¾ç£¬£¬£¬ÅÁ½ðÉ­²¡»¼ÕßµÄÊýÄ¿»¹ÔÚÒ»Ö±ÅÊÉý£¬£¬£¬¸øÉç»áºÍ¼ÒÍ¥´øÀ´ÁËÖØ´ó¾­¼ÃѹÁ¦ºÍ¼ç¸º£¬£¬£¬Í¬Ê±Ò²ÑÏÖØÍþвÈËÃñµÄÉúÃü¿µ½¡ºÍÉúÑÄÖÊÁ¿¡£¡£¡£¡£¿ÉÊÇ£¬£¬£¬ÏÖÔÚPDÐγɵÄÏêϸ»úÖÆÉв»ÍêÈ«Ã÷È·£¬£¬£¬PDÈÔºÜÄÑÖÎÓú¡£¡£¡£¡£ÕýÒòÔÆÔÆ£¬£¬£¬¿ª·¢ÐµĹ¤¾ß¸¨ÖúPDµÄÔçÆÚÕï¶ÏºÍÖÎÁÆÏԵúÜÊÇÖ÷Òª¡£¡£¡£¡£½üÄêÀ´£¬£¬£¬Ó«¹â̽Õë×÷ΪһÖÖ¹¦Ð§Ç¿Ê¢µÄÉúÎï³ÉÏñ¹¤¾ß£¬£¬£¬Í¨¹ý¶ÔÅÁ½ðÉ­²¡²¡ÀíÌØÕ÷µÄ¼ì²âºÍ¼à²â£¬£¬£¬ÓÐÍû×ÊÖúÏàʶÅÁ½ðÉ­²¡ÐγɵÄÏêϸ²¡ÀíÀú³Ì£¬£¬£¬¶ÔPDµÄÔçÆÚÕï¶ÏºÍÖÎÁƾßÓкÜÊÇÖ÷ÒªµÄ×÷Óᣡ£¡£¡£

¿ËÈÕ£¬£¬£¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¿ÎÌâ×é¼°ÆäÏàÖúµÄÑо¿ÍŶÓÖÜÈ«±¨µÀÁËÅÁ½ðÉ­²¡Ç±ÔÚÉúÎï±ê¼ÇÎïµÄÉúÎï³ÉÏñÓ«¹â̽ÕëÏà¹ØÏ£Íû£¬£¬£¬ÒÔ¡°Fluorescent probes for bioimaging of potential biomarkers in Parkinson¡¯s disease¡±ÎªÌâ½ÒÏþÔÚ¹ú¼Ê»¯Ñ§È¨Íþ¶¥¼âÔÓÖ¾Chemical Society Reviews£¨IF 42.846, DOI: 10.1039/d0cs00115e£©ÉÏ¡£¡£¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ͼ1. ÅÁ½ðÉ­²¡Ç±ÔÚÉúÎï±ê¼ÇÎï¼°ÆäÉúÎï³ÉÏñÓ«¹â̽Õë

PDÖ÷ÒªÌåÏÖΪÖÐÄÔºÚÖʶà°Í°·ÄÜÉñ¾­Ôª¹¦Ð§È±Ê§£¬£¬£¬ÆäÖ÷Òª²¡ÀíÌØÕ÷°üÀ¨¦Á-Í»³öºËÂÑ°×£¨a-Synuclein£¬£¬£¬a-syn£©Òì³£»ýÀÛȺ¼¯¡¢¡¢¡¢½ðÊôÀë×Óƽºâʧµ÷¡¢¡¢¡¢Ñõ»¯Ó¦¼¤¡¢¡¢¡¢ÏßÁ£Ì幦ЧÕÏ°­ºÍÉñ¾­µÝÖÊȱ·¦µÈ¡£¡£¡£¡£±¾ÎÄÖÜÈ«×ܽáºÍ±¨µÀÁËÓ«¹â̽ÕëµÄÉè¼Æ¡¢¡¢¡¢·¢¹â»úÀí¼°ÆäÔÚÖÖÖÖPDÉúÎï±ê¼ÇÎï¼ì²âÖеÄÓ¦Óᣡ£¡£¡£Ê×ÏÈ£¬£¬£¬±¾ÎĽéÉÜÁËÏÖÔÚPDÉúÎïÓ«¹â³ÉÏñµÄÏÖ×´£¬£¬£¬²¢×ܽáÆÊÎöÁËPDDZÔڰбêµÄÓ«¹â̽ÕëµÄ×ܵÄÉè¼ÆÕ½ÂÔ£»È»ºó£¬£¬£¬ÒÔa-syn£¬£¬£¬µ¥°·Ñõ»¯Ã¸B£¬£¬£¬¶à°Í°·Ïà¹Øµ÷ÀíÒò×Ó£¬£¬£¬½ðÊôÀë×Ó£¬£¬£¬»îÐÔÑõ£¬£¬£¬»îÐÔÁòµÈDZÔڰбê·ÖÀà½éÉÜÁËÕâЩ±ê¼ÇÎïµÄÓ«¹â̽ÕëµÄÉè¼ÆÔ­Àí£¬£¬£¬³ÉÏñ»úÀí¡¢¡¢¡¢ÉúÎïÓ¦ÓùæÄ£ÒÔ¼°±£´æµÄȱ·¦£¬£¬£¬ÕâЩ̽Õë·Ö×ÓÀàÐÍ°üÀ¨£º£º£ºÈº¼¯ÓÕµ¼Ð¡·Ö×Ó£¬£¬£¬¹ý¶É½ðÊô¸´ºÏÎ£¬£¬½üºìÍâÓ«¹â·Ö×Ó£¬£¬£¬Ë«¹â×ÓС·Ö×ÓÒÔ¼°»ùÓÚ·´Ó³Ð͵ĶàëĺÍС·Ö×ӵȡ£¡£¡£¡£×îºó£¬£¬£¬ÎÄÕÂÌá³öÁËPDÉúÎï³ÉÏñµÄ̽Õ뿪չÐèÒª¶àѧ¿Æ½»Ö¯¡¢¡¢¡¢¶àÕ½ÂÔÁªºÏÓ¦Ó㬣¬£¬ÈçÒ©Îﻯѧ£¬£¬£¬ÉúÎﻯѧ£¬£¬£¬ÖÊÁÏ»¯Ñ§µÈѧ¿Æ½»Ö¯ÒÔ¼°Èº¼¯ÓÕµ¼·¢¹âÖÊÁÏ¡¢¡¢¡¢½üºìÍâ̽Õë¡¢¡¢¡¢Î¢ÕóÁк͡°Ò»ÖéÒ»»¯ºÏÎµÄ¸ßͨÁ¿É¸Ñ¡¡¢¡¢¡¢DNA±àÂë¿âµÈ¶àÕ½ÂÔµÄÁªºÏÓ¦Ó㬣¬£¬½ø¶øΪÒÔºóÉè¼Æ³öÌØÒìÐÔ¸üºÃ¡¢¡¢¡¢Ñ¸Ëٶȸü¸ßµÄPDÓ«¹â̽ÕëÓÃÓÚPD¼²²¡µÄÔçÆÚÕï¶Ï¡¢¡¢¡¢·¢²¡»úÖƵÄ̽ÌÖÒÔ¼°Ñз¢¸üºÃµÄÓÃÓÚPD²¡È˵ÄÖÎÁÆÒ©ÎïÌṩÓмÛÖµµÄÐÅÏ¢¡£¡£¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ͼ2. PDÓ«¹â̽ÕëµÄÀíÐÔÉè¼ÆÕ½ÂÔ

ÔÚÕâÏîÊÂÇéÖУ¬£¬£¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¸±½ÌÊÚ¡¢¡¢¡¢²©Ê¿ÉúÍôΰ¡¢¡¢¡¢Ë¶Ê¿ÉúÍõè¯ÎªÎÄÕµÄÅäºÏµÚÒ»×÷Õߣ¬£¬£¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¸±½ÌÊÚ¡¢¡¢¡¢Ð¤Ææ²Å¸±Ñо¿Ô±ºÍмÓƹúÁ¢´óѧ»¯Ñ§ÏµÒ¦ÉÙÇÕ½ÌÊÚΪÎÄÕµÄͨѶ×÷Õß¡£¡£¡£¡£±ðµÄ£¬£¬£¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©µÄÑî·Ò²©Ê¿¡¢¡¢¡¢Ë¶Ê¿ÉúлÁõÐÒ¡¢¡¢¡¢ngµç×ÓÓÎÏ·ËïÒÝÏɼÍÄîÒ½ÔºÉò¾ý½ÌÊÚ¡¢¡¢¡¢ÐÂÎ÷À¼°Â¿ËÀ¼´óѧMargaret A. BrimbleԺʿҲ¼ÓÈëÁËÕâÏîÊÂÇé²¢¸øÓèÁËÐí¶à×ÊÖúºÍÖ§³Ö¡£¡£¡£¡£

´ËÏîÊÂÇéÊܵ½Á˹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬£¬£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð-¹ã¶«Ê¡ÁªºÏ»ù½ð¼¯³ÉÏîÄ¿£¬£¬£¬¹ã¶«Ê¡¿Æ¼¼ÌüÖصãÑз¢ÍýÏ룬£¬£¬ÉîÛÚÊпƴ´Î¯×ÔÓÉ̽Ë÷ºÍÖÐÑë¸ßУngµç×ÓÓÎÏ·ÇàÄêÎ÷ϯÅàÓýÏîÄ¿£¬£¬£¬¹ã¶«Ê¡¡°Ö齭ѧÕß¡±ºÍмÓƹú¼ÒÑо¿»ù½ð»áµÈÏîÄ¿µÄ×ÊÖú¡£¡£¡£¡£

ÂÛÎÄÁ´½Ó: https://pubs.rsc.org/en/content/articlelanding/2021/CS/D0CS00115E#!divAbstract

¡¾ÍøÕ¾µØͼ¡¿